VC  Solas BioVentures

     Office Locations:

105 Continental Place, Suite 350
Brentwood, TN 37027

Get all office locations for this firm with a National Database subscription.


  • Early



  • Life Sciences & Healthcare
  • Medical Device



    Solas BioVentures is a biotechnology and medical device venture capital fund founded by Casey Hammontree in 2014. Hammontree is currently a partner at Tenth Street Capital. Solas BioVentures focuses on early stage biopharmaceuticals, medical devices, diagnostics, digital health technologies and related opportunities in medicine.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    David Adair MD, MBA Managing Director and Co-Founder
    David Belitz MBA Partner
    Joshua Eckelberry MBA Principal
    Mark Hackett JD Co-Founder and Partner
    Michael Ackermann PhD, MBA Managing Director


    Recent Funding Events (trailing 12 months):







      Dimension Inx



      Series A


    Portfolio companies include:


    Recent News: